CDMO News
SMC Pharma Services Partners to Develop Autoinjector for Genetic Rare Diseases
SMC Pharma Services has entered into a development agreement with a commercial-stage biopharmaceutical company focused on therapies for genetic rare diseases. This collaboration aims to develop an autoinjector platform solution for clinical trials scheduled for 2026. The partnership will utilise
23 October 2024